Navigation Links
Harwood Feffer LLP Announces Investigation of Geron Corporation

NEW YORK, April 29, 2015 /PRNewswire/ -- Harwood Feffer LLP ( is investigating potential claims against the board of directors (the "Board") of Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN), concerning whether the Board members breached their fiduciary duties to shareholders.

On April 10, 2015, the United States District Court for the Northern District of California sustained in part a securities class action complaint filed against Geron and certain of its officers and directors in connection with alleged material misstatements concerning clinical trials of a new drug between June 16, 2013 and March 11, 2014.  During this period, Geron's officers and directors may have known that patients treated with the drug exhibited liver function abnormalities putting them at risk for chronic liver injury but nonetheless made statements to the public that the drug was safe and well-tolerated.  When the Food and Drug Administration (FDA) put a hold on the drug's clinical trials on March 11, 2014, due to these liver toxicity concerns, Geron's stock plummeted 62%.

Our investigation concerns whether the Company's officers and directors breached their fiduciary duties by making or causing to be made misleading statements regarding the clinical trials.  We are also investigating whether the Board breached its fiduciary duties to shareholders and exposed the Company to significant civil liability, including damages and litigation costs in connection with the securities class action referenced above.

If you own Geron shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Samuel K. Rosen, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers:
(877) 935-7400
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ( for more information about the firm. 

The law firm responsible for this advertisement is Harwood Feffer LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo -


SOURCE Harwood Feffer LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of OvaScience, Inc.
2. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
3. Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
4. Harwood Feffer LLP Announces Investigation of Santarus, Inc.
5. Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
6. Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
7. Harwood Feffer LLP Announces Investigation of Advaxis, Inc.
8. Harwood Feffer LLP Announces Investigation of Acadia Pharmaceuticals Inc.
9. Harwood Feffer LLP Announces Investigation of Dietary Supplements Containing BMPEA
10. Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc.
11. Pharmagen Announces First Quarter 2013 Results
Post Your Comments:
(Date:11/16/2019)... ... , ... October 29 article on WFLA offers the post-holiday ... usual is being consumed – is best done near other meal times, as this ... acids found in candy are more likely to be neutralized, significantly reducing the chances ...
(Date:11/14/2019)... ... November 14, 2019 , ... ... double-blind, placebo-controlled human clinical trials using AstaZine® on brain health. , ... including feelings of depression, mental fatigue and overall mood state [psychological well-being] were ...
(Date:11/14/2019)... ... November 14, 2019 , ... Bioclinica Medical Imaging, the world ... reached a milestone in the company’s history: the company has contributed reliable data ... clients for therapies and indications subsequently approved by the U.S. Food and Drug ...
Breaking Medicine Technology:
(Date:11/19/2019)... ... November 18, 2019 , ... “Impact of the ... Kindy has been named No. 1 International Best Seller and Hot New Release ... Energy Healing, Nosology, and Alternative Medicine. , Kindy’s study investigated the impact ...
(Date:11/16/2019)... VEGAS (PRWEB) , ... November 15, 2019 , ... ... seen before in the United States, access to cannabis via well-managed dispensaries becomes ... marijuana industry. Wise Business Plans, industry-leading online provider of state-of-the-art, online, custom cannabis ...
(Date:11/15/2019)... ... November 15, 2019 , ... DataTribe , ... science companies with nation-state experienced technical teams from the intelligence community, research labs, ... Code Dx Inc ., based in Northport, New York. , ...
(Date:11/14/2019)... Maine (PRWEB) , ... November ... ... releases VALIDATE® SP1 linearity and calibration verification kit, specifically targeted for Roche ... a human-serum matrix, evaluates a1-Antitrypsin (ATT), Complement C3 (C3), Complement C4 (C4), ...
(Date:11/14/2019)... Mass. (PRWEB) , ... November 14, 2019 , ... With winter just around the corner, ... car rides. While padded jackets and overalls might keep little ones warm, during a car ... system on a car seat must fit snugly in order to ensure maximum safety during ...
Breaking Medicine News(10 mins):